Phase 1/2 Study Evaluating the Safety, PK/PD, and Clinical Activity of Oral JBI-778 in Patients With Brain Metastases, Leptomeningeal Disease, or Recurrent High Grade Glioma

Clinical trial NCT07751744 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07751744
Sponsor: Jubilant Therapeutics Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Brain Metastases From Solid Tumors Leptomeningeal Disease High Grade Glioma (HGG)Glioblastoma (GBM)

Start date: 2028-04-01
Primary completion: 2030-03-31
Enrollment: 113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.